Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19. Faguer S, Del Bello A, Abravanel F, Nicolau-Travers ML, et al. Ann Intern Med 2020 May 18. doi: 10.7326/L20-0419.

Read + Share

Amedeo Smart

Independent Medical Education

Faguer S, Del Bello A, Abravanel F, Nicolau-Travers ML, et al. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19. Ann Intern Med 2020 May 18. doi: 10.7326/L20-0419.
PMID: 32432518